摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(6S,7R,8R,8aS)-6,7,8-trihydroxy-hexahydro-1H-indolizin-5-one | 1407965-70-1

中文名称
——
中文别名
——
英文名称
(6S,7R,8R,8aS)-6,7,8-trihydroxy-hexahydro-1H-indolizin-5-one
英文别名
(6S,7R,8R,8aS)-6,7,8-trihydroxyhexahydroindolizin-5(1H)-one;(6S,7R,8R,8aS)-6,7,8-trihydroxy-2,3,6,7,8,8a-hexahydro-1H-indolizin-5-one
(6S,7R,8R,8aS)-6,7,8-trihydroxy-hexahydro-1H-indolizin-5-one化学式
CAS
1407965-70-1
化学式
C8H13NO4
mdl
——
分子量
187.196
InChiKey
JGJWMVRFUAOMHZ-WNJXEPBRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.93
  • 重原子数:
    13.0
  • 可旋转键数:
    0.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.88
  • 拓扑面积:
    81.0
  • 氢给体数:
    3.0
  • 氢受体数:
    4.0

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (6S,7R,8R,8aS)-6,7,8-trihydroxy-hexahydro-1H-indolizin-5-onedimethyl sulfide borane 作用下, 以 四氢呋喃乙醇 为溶剂, 反应 7.0h, 以82%的产率得到(-)-(6R,7S,8R,8aS)-6,7,8-trihydroxyindolizidine
    参考文献:
    名称:
    Total synthesis of 1-deoxy-7,8a-di-epi-castanospermine and formal synthesis of pumiliotoxin-251D
    摘要:
    A concise and efficient synthesis of (6R,7S,8R,8aS)-6,7,8-trihydroxyindolizidine (1-deoxy-7,8a-di-epi-castanospermine) 2 is described. The synthesis employs cross metathesis in building the key intermediate 9 and is used effectively in constructing indolizidine skeleton for the total synthesis of 1-deoxy-7, 8a-di-epi-castanospermine and also for the bicyclic framework of pumiliotoxin 251D 12,13. The indolizidine skeleton is achieved in one pot sequence of transformations such as deprotection of Cbz group, reduction of double bond, and cyclization. The configurational and conformational structures of compound 10 are unambiguously confirmed by X-ray analysis. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2012.08.061
  • 作为产物:
    参考文献:
    名称:
    Total synthesis of 1-deoxy-7,8a-di-epi-castanospermine and formal synthesis of pumiliotoxin-251D
    摘要:
    A concise and efficient synthesis of (6R,7S,8R,8aS)-6,7,8-trihydroxyindolizidine (1-deoxy-7,8a-di-epi-castanospermine) 2 is described. The synthesis employs cross metathesis in building the key intermediate 9 and is used effectively in constructing indolizidine skeleton for the total synthesis of 1-deoxy-7, 8a-di-epi-castanospermine and also for the bicyclic framework of pumiliotoxin 251D 12,13. The indolizidine skeleton is achieved in one pot sequence of transformations such as deprotection of Cbz group, reduction of double bond, and cyclization. The configurational and conformational structures of compound 10 are unambiguously confirmed by X-ray analysis. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2012.08.061
点击查看最新优质反应信息

文献信息

  • α,β-Unsaturated Diazoketones as Platforms in the Asymmetric Synthesis of Hydroxylated Alkaloids. Total Synthesis of 1-Deoxy-8,8a-diepicastanospermine and 1,6-Dideoxyepicastanospermine and Formal Synthesis of Pumiliotoxin 251D
    作者:Barbara Bernardim、Vagner D. Pinho、Antonio C. B. Burtoloso
    DOI:10.1021/jo301967w
    日期:2012.11.2
    A versatile and concise approach for the stereoselective synthesis of mono-, di-, and trihydroxylated indolizidines is presented in four to six steps from Cbz-prolinal and a diazophosphonate. The key steps involved a Wolff rearrangement, followed by a stereoselective dihydroxylation/epoxidation reaction, from an α,β-unsaturated diazoketone. The strategy also permits extension to the synthesis of many
    从Cbz-脯酸和重氮膦酸酯的四至六个步骤中提出了一种立体选择性合成单羟基,二羟基和三羟基吲哚吡啶的通用且简洁的方法。关键步骤涉及沃尔夫夫重排,然后是来自α,β-不饱和重氮酮的立体选择性二羟基化/环氧化反应。该策略还允许扩展到许多天然羟基化的吲哚并立定生物碱的合成,如pumiliotoxin 251D的正式合成所证明的。
查看更多

同类化合物

颈花脒 罗拉西坦 矛裂碱 甲基六氢-1H-吡咯里嗪-1-羧酸酯 瓶千里光碱N-氧化物 新瓶草千里光碱 异款冬碱 季普拉嗪 四氢-1H-吡咯里嗪-2(3H)-酮 四氢-1H-吡咯烷-7a(5H)-乙酸 四氢-1H-吡咯并吡咯烷-7a(5H)-乙胺二盐酸盐 四氢-1H-吡咯嗪-7a(5h)-乙酸乙酯 响铃豆碱 去甲一叶秋碱 六氢-吡咯嗪-1-酮 六氢-3-(羟甲基)-1H-吡咯里嗪-1,2,7-三醇 六氢-1H-吡咯里嗪-2-羧酸 六氢-1H-吡咯里嗪-2-甲腈 六氢-1H-吡咯里嗪 六氢-1H-吡咯嗪-7A-甲腈 倒千里光裂醇 二[[(1R,8R)-2,3,5,6,7,8-六氢-1H-吡咯里嗪-1-基]甲基]2,4-二(4-羟基苯基)环丁烷-1,3-二羧酸酯 [(1S,8R)-2,3,5,6,7,8-六氢-1H-吡咯里嗪-1-基]甲醇 [(1S,7R,8R)-7-[(Z)-2-甲基丁-2-烯酰基]氧基-2,3,5,6,7,8-六氢-1H-吡咯里嗪-1-基]甲基 (Z)-2-(羟基甲基)丁-2-烯酸酯 7a-乙氧基-7,7-二甲基六氢-3H-吡咯里嗪-3-酮 7Alpha-双稠吡咯啶-乙酸盐酸盐 7Alpha-双稠吡咯啶-乙腈 7-羟基-1-氮杂双环[5.3.0]癸烷-2-酮 7-甲基六氢-1H-吡咯里嗪-1-酮 7,8-二羟基-4'-甲氧基异黄酮 5-甲氧羰基甲基-1-氮杂双环[3.3.0]辛烷 5-氧代六氢-1H-吡咯里嗪-1-甲醛 5-(2-氨基乙基)-1-氮杂双环[3.3.0]辛烷 3-(羟基甲基)六氢-1H-吡咯里嗪-1,2,7-三醇盐酸盐(1:1) 2,3,5,6,7,8-六氢-1H-吡咯里嗪-1-胺 2(1H)-喹喔啉酮,3-氨基-7-甲基- 1H-吡咯啉嗪-2-胺,六氢-(9CI) 1H-吡咯啉嗪-1-酮,六氢-7-(羟甲基)- 1-氮杂二环[2.2.1]庚烷,3-(5-异[口噁]唑基)-,外-(9CI) 1-(六氢-1H-吡咯里嗪-1-基)乙酮 (六氢-1H-吡咯里嗪-7A-基)甲胺 (六氢-1H-吡咯啉-7a-基)甲醇 (八氢吲哚嗪-8A-基)甲胺 (八氢-9AH-喹啉嗪-9A-基)甲醇 (Z)-2-甲基-2-丁烯酸[(1S,2R,7aS)-六氢-1-羟基甲基-1H-吡咯里嗪-2-基]酯 (Z)-2-甲基-2-丁烯酸[(1S,2R,7aR)-六氢-2beta-羟基-1H-吡咯里嗪-1beta-基]甲基酯 (7aS)-四氢-1H-吡咯里嗪-2(3H)-酮 (7aS)-六氢-3H-吡咯里嗪-3-酮 (7aS)-2-甲基四氢-1H-吡咯里嗪-1,3(2H)-二酮 (7a-甲基六氢-1H-吡咯里嗪-1-基)甲醇